Amambay Riquelme

graph of relations

Publications

  1. 2023
  2. Combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric ALK-positive anaplastic large cell lymphoma

    Knörr, F., Schellekens, K. P. J., Schoot, R. A., Landman-Parker, J., Teltschik, H-M., Förster, J., Riquelme, A., Huitema, A. D. R., Van Eijkelenburg, N. K. A., Beishuizen, A., Zwaan, C. M., Woessmann, W. & Van der Lugt, J., 01.05.2023, In: HAEMATOLOGICA. 108, 5, p. 1442-1446 5 p.

    Research output: SCORING: Contribution to journalLetterResearchpeer-review

  3. 2022
  4. Characterization of IG-MYC-breakpoints and their application for quantitative minimal disease monitoring in high-risk pediatric Burkitt-lymphoma and -leukemia

    Möker, P., Zur Stadt, U., Zimmermann, M., Alawi, M., Mueller, S., Finger, J., Knörr, F., Riquelme, A., Oschlies, I., Klapper, W., Bradtke, J., Burkhardt, B., Woessmann, W. & Damm-Welk, C., 09.2022, In: LEUKEMIA. 36, 9, p. 2343-2346 4 p.

    Research output: SCORING: Contribution to journalLetterResearch